# Nagrani Mark, Md, New Smyrna Beach, FL – FDA Inspections

Source: https://www.keypedia.com/companies/nagrani-mark-md/e093f928-7703-47df-8108-f2481c6f03a8

> Inspection records and compliance data for Nagrani Mark, Md in New Smyrna Beach, Florida. 1 FDA inspection on record, last inspected February 04, 2010.

---

## Details

- Name: Nagrani Mark, Md
- FEI Number: 3008102296
- Address Line 1: 612 Palmetto St
- City: New Smyrna Beach
- State: Florida
- Zip Code: 32168
- Country Name: United States
- Address: 612 Palmetto St, New Smyrna Beach, Florida 32168, United States
- Country: United States

## Related Documents

- FDA Inspection 644628 - Nagrani Mark, Md - 2010-02-04 — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2010

## Related Companies

- [Linzer, Dov M.D.](https://www.keypedia.com/companies/linzer-dov-md/c2fe5c2e-5f38-4954-a222-e0d98fcad16c)
- [Cystic Fibrosis Pharmacy, Inc.](https://www.keypedia.com/companies/cystic-fibrosis-pharmacy-inc/13745249-b525-458d-85aa-04cce87d1319)
- [Gil Fernandez-Yera, M.D.](https://www.keypedia.com/companies/gil-fernandez-yera-md/19e9ef15-d5b2-4527-b887-1aa7ec4584f8)
- [Lincare, Inc.](https://www.keypedia.com/companies/lincare-inc/ef167cbd-5f25-45e5-8bc7-1ea99ab07d75)
- [Clinical Pharmacology of Miami, Inc](https://www.keypedia.com/companies/clinical-pharmacology-of-miami-inc/f97da50e-cdff-4653-b23a-45742b1e66c9)
- [Michael E. Schwartz, D.O.](https://www.keypedia.com/companies/michael-e-schwartz-do/cbd0965f-5de8-4295-b9df-d5930c34e2e3)
- [Marc Saltzman](https://www.keypedia.com/companies/marc-saltzman/1876427d-4a5a-46d1-9700-232a0f68986f)
- [Kohen, Michael, M.D.](https://www.keypedia.com/companies/kohen-michael-md/7c6c18fb-5501-4f28-948c-5be71971c4df)
- [Forward Clinical Trials, Inc.](https://www.keypedia.com/companies/forward-clinical-trials-inc/54067027-d152-4893-a0d6-8c12a1d4c8ce)
- [Sander Fernandez, M.D.](https://www.keypedia.com/companies/sander-fernandez-md/084f9e59-a95d-4708-9819-a79632b21676)